XML 80 R41.htm IDEA: XBRL DOCUMENT v3.22.4
Share-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Weighted Average Option Fair Values and Assumptions
Weighted average option fair values and assumptions for the periods specified are as follows:
 Years Ended December 31,
 202220212020
Weighted average fair value of grants$42.66$38.88$34.22
Dividend yield1.14%1.01%1.15%
Volatility25.23%23.78%22.04%
Risk-free interest rate2.01%
0.12% - 1.54%
1.39% - 1.66%
Expected life (in years)4.905.705.80
Schedule of Stock Option Activity
A summary of the Company’s stock option activity as of December 31, 2022, and changes during the year ended December 31, 2022 is presented as follows:
SharesWeighted
Average
Price		Weighted-Average
Remaining
Contractual Term
(years)		Aggregate
Intrinsic
Value
(Dollars in millions except weighted average price)
Stock Options
Outstanding at January 1, 20221,008,586 $147.60 6.97$89.5 
Granted288,855 190.43 
Exercised(171,061)112.67 
Forfeited/Expired(110,808)186.25 
Outstanding at December 31, 20221,015,572 $161.45 6.94$67.9 
Vested and expected to vest at December 31, 2022982,705 $160.46 6.88$66.7 
Exercisable at December 31, 2022489,720 $134.20 5.41$46.1 
Schedule of Compensation Cost for Stock Options
Total compensation cost for stock options is recorded in the Consolidated Statements of Income as follows:
 Years Ended December 31,
 202220212020
 (In millions)
Cost of goods sold$0.5 $0.5 $0.5 
Selling, general and administrative expenses8.7 8.0 7.6 
Total expense before income taxes9.2 8.5 8.1 
Income tax benefit(0.8)(0.8)(0.9)
Total expense after income taxes$8.4 $7.7 $7.2 
Schedule of Restricted Stock Activity A summary of the Company’s restricted stock activity as of December 31, 2022, and changes during the year ended December 31, 2022 is as follows:
Restricted StockSharesWeighted-Average
Grant Date Fair
Value
Unvested at January 1, 2022107,475 $169.58 
Granted56,200 192.72 
Vested(30,786)157.63 
Forfeited(28,507)191.95 
Unvested at December 31, 2022104,382 $179.45 
Schedule of Compensation Cost for Restricted Stock
Total compensation cost for restricted stock is recorded in the Consolidated Statements of Income as follows:
 Years Ended December 31,
 202220212020
 (In millions)
Cost of goods sold$0.3 $0.4 $0.3 
Selling, general and administrative expenses6.4 5.1 3.9 
Total expense before income taxes6.7 5.5 4.2 
Income tax benefit(1.2)(1.1)(0.9)
Total expense after income taxes$5.5 $4.4 $3.3 
Schedule of Unvested Cash-settled Restricted Stock Activity A summary of the Company’s unvested cash-settled restricted stock activity as of December 31, 2022, and changes during the year ended December 31, 2022 is as follows:
Cash-Settled Restricted StockSharesWeighted-Average
Fair Value
Unvested at January 1, 202257,949 $236.32 
Granted27,375 196.20 
Vested(20,676)190.67 
Forfeited(7,292)228.33 
Unvested at December 31, 202257,356 $228.33 
Schedule of Compensation Cost for Unvested Cash-settled Restricted Stock
Total compensation cost for cash-settled restricted stock is recorded in the Consolidated Statements of Income as follows:

Years Ended December 31,
202220212020
 (In millions)
Cost of goods sold$0.1 $0.7 $0.9 
Selling, general and administrative expenses2.6 4.3 3.7 
Total expense before income taxes2.7 5.0 4.6 
Income tax benefit(0.2)(0.4)(0.4)
Total expense after income taxes$2.5 $4.6 $4.2 
Schedule of Weighted Average Performance Share Units Fair Values and Assumptions
Weighted average performance share unit fair values and assumptions for the period specified are as follows:
Years Ended December 31,
 202220212020
Weighted average fair value of grants$235.54$247.49$224.14
Dividend yield—%—%—%
Volatility28.09%28.60%19.50%
Risk-free interest rate1.73%0.33%1.30%
Expected life (in years)2.932.932.94
Schedule of Performance Shares Units Activity
A summary of the Company’s performance share unit activity as of December 31, 2022, and changes during the year ended December 31, 2022, is as follows:
Performance Share UnitsSharesWeighted-Average
Grant Date Fair
Value
Unvested at January 1, 202252,025 $236.75 
Granted31,370 235.54 
Vested(1)
— — 
Forfeited(12,480)235.88 
Unvested at December 31, 202270,915 $236.66 

(1) The performance period for the 2020 grants ended as of January 31, 2023. The 2020 grants achieved a 173% payout factor and the Company issued 31,334 common shares in February 2023 for awards that vested in 2023.
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Total compensation cost for performance share units is recorded in the Consolidated Statements of Income as follows:
Years Ended December 31,
202220212020
(In millions)
Cost of goods sold$— $— $— 
Selling, general and administrative expenses6.0 6.4 2.6 
Total expense before income taxes6.0 6.4 2.6 
Income tax benefit(0.2)(0.3)(0.2)
Total expense after income taxes$5.8 $6.1 $2.4